Asian Journal of Biomedical and Pharmaceutical Sciences

Reach Us +1 (202) 780-3397

Pharmacovigilance Journals Impact Factor

Pharmacovigilance begins with scientific trials that provide statistics on the benefits and threats of a drug. The aim of pharmacovigilance in medical research is to regulate if the benefits overshadow the risks; if they do, drug producers take steps to gain approval to market the new drug. Phase I, II, and III clinical trials are needed before a drug company can apply for a new medication’s market agreement. In these studies, the principle detective is the main point of contact at the trial site. They are accountable for the behaviour of the investigation and then feed it back to the supporter (the pharma company). During clinical trials, the detective collects and scrutinizes data on serious adverse events (SAEs), determining whether the drug in question caused the SAEs. If they conclude that the negative side possessions were causal, they are categorized as hostile drug reactions (ADRs).

High Impact List of Articles
Conference Proceedings

Relevant Topics in Medical Sciences

Get the App